3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
2
Carcinoma in Situ
2
Vulvar Neoplasms
1
Vulvar Diseases
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Rectal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Papillomavirus Infections
1
Oropharyngeal Neoplasms
1
Lymphoma, Follicular
1
Leukemia, Hairy Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma
1
Burkitt Lymphoma
1
Anus Neoplasms
1
Interventions
Rituximab
30
acalabrutinib
15
ibrutinib
13
Cyclophosphamide
13
Lenalidomide
12
CT-P10
12
zanubrutinib
9
venetoclax
9
Magnetic Resonance Spectroscopy
9
Specimen Handling
8
obinutuzumab
7
Cytarabine
7
Biopsy
7
Bendamustine Hydrochloride
7
pirtobrutinib
6
glofitamab
6
fludarabine
6
fludarabine phosphate
5
Peripheral Blood Stem Cell Transplantation
5
Cyclosporine
5
brexucabtagene autoleucel
4
Whole-Body Irradiation
4
Vincristine
4
Mycophenolic Acid
4
Etoposide
4
Doxorubicin
4
Stem Cell Transplantation
3
Sirolimus
3
Methotrexate
3
Cyclosporins
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Mantle-Cell
×
Diphenhydramine
×
90 days
×
Clear all
No trials found.